FDA Guideline: Real-World Data Sources: Claims, EHR, Registries & Digital Health Data
Using digital health and wearable data streams as real world data sources
Using Digital Health and Wearable Data Streams as Real World Data Sources The integration of digital health technologies and wearable data into clinical research presents an unprecedented opportunity for pharmaceutical and medtech professionals. As part of the ongoing evolution in the healthcare landscape, real world data (RWD), which includes data from various sources such as claims, electronic health records (EHRs), patient registries, and wearable devices, has gained significant attention for its potential to support regulatory decision-making and improve patient outcomes. This step-by-step tutorial provides a comprehensive overview of how to utilize digital health and wearable data streams as real world…
Designing disease and product registries that meet FDA RWE expectations
Designing Disease and Product Registries that Meet FDA RWE Expectations Introduction to Real-World Evidence (RWE) and Registries In the evolving landscape of healthcare, increasingly diverse sources of data are being utilized to support regulatory decision-making and post-market surveillance. Real-world evidence (RWE) provides insights derived from real-world data (RWD), which includes data on patient health outcomes and healthcare utilization, often captured through electronic health records (EHR), claims data, registries, and digital health platforms. As regulatory agencies, especially the US FDA, emphasize integrating RWE into their frameworks, professionals in pharma and medtech must understand how to design disease and product registries that…
Leveraging EHR data for regulatory grade real world evidence studies
Leveraging EHR Data for Regulatory Grade Real World Evidence Studies In recent years, there has been a growing emphasis on the utilization of Real World Data (RWD) within the pharmaceutical and medical technology sectors. This has largely been driven by the need for evidence that supports the effectiveness and safety of products in current clinical settings. Electronic Health Records (EHR) serve as a critical foundation for much of this research. This tutorial aims to provide a detailed, step-by-step approach on how to leverage EHR data for regulatory-grade Real World Evidence (RWE) studies, tailored for professionals in regulatory affairs, biostatistics, health…
Strengths and weaknesses of claims databases for RWE generation
Strengths and Weaknesses of Claims Databases for RWE Generation Real-world data (RWD) generation has become a pivotal aspect of evidence generation in healthcare. It leverages diverse data sources, including claims databases, electronic health records (EHRs), patient registries, and digital health data, to enhance decision-making in medical product development, regulatory review, and post-market evaluations. This article provides a detailed exploration of the strengths and weaknesses of claims databases as a source for generating real-world evidence (RWE), while aligning with US FDA expectations and considering EU and UK perspectives. Understanding Claims Databases Claims databases consist of records created when healthcare services are…
Real world data sources overview claims EHR registries and digital health data
Comprehensive Overview of Real-World Data Sources: Claims, EHR, Registries, and Digital Health Data The evolution of healthcare delivery has been influenced significantly by the integration and utilization of real-world data (RWD) in decision-making processes. This article will provide an in-depth analysis of real-world data sources, including claims data, electronic health records (EHR), patient registries, and digital health data, particularly in the context of United States Food and Drug Administration (FDA) regulations and guidance. Understanding Real-World Data and Evidence: Defining the Terms Real-world data (RWD) refers to data collected from various sources, outside traditional controlled clinical trials, that reflect the outcomes…
Global RWD landscapes in US, EU and UK and implications for RWE
Understanding Global Real-World Data Landscapes: Implications for Real-World Evidence As the pharmaceutical and medtech industries increasingly rely on real-world data (RWD) to inform and support regulatory decision-making, it becomes essential to comprehend the broad array of data sources available and the regulatory frameworks governing their use. This tutorial serves as a comprehensive guide for professionals involved in regulatory affairs, biostatistics, health economics and outcomes research (HEOR), and data standards. It will explore real-world data sources such as claims, electronic health records (EHR), patient registries, and digital health data across the US, EU, and UK landscapes. Step 1: Defining Real-World Data…
Handling missingness and coding variability across RWD sources
Handling Missingness and Coding Variability Across RWD Sources Handling Missingness and Coding Variability Across RWD Sources Real-World Data (RWD) has increasingly become pivotal for generating insights into patient outcomes and treatment efficacy in the pharmaceutical and medtech industries. However, significant challenges arise, particularly regarding missingness and coding variability across diverse data sources such as claims data, Electronic Health Records (EHRs), patient registries, and digital health data. This comprehensive guide provides a step-by-step tutorial for navigating these complexities, ensuring regulatory compliance, and optimizing data utilization for real-world evidence (RWE). Understanding Real-World Data Sources Real-World Data encompasses various non-experimental data sources that…
Case studies of RWD source selection in successful RWE submissions
Case studies of RWD source selection in successful RWE submissions Case Studies of RWD Source Selection in Successful RWE Submissions In the realm of pharmaceutical and medical device development, the integration of Real-World Data (RWD) into evidence generation has transformed the landscape of regulatory submissions. This article aims to provide a comprehensive guide on the selection of Real-World Data Sources, focusing on case studies that demonstrate successful Real-World Evidence (RWE) submissions. Understanding the nuances of RWD, including claims data, Electronic Health Records (EHR), patient registries, and digital health data is crucial for regulatory, biostatistics, Health Economics and Outcomes Research (HEOR),…
Data partner selection criteria for high value RWD collaborations
Data Partner Selection Criteria for High Value RWD Collaborations In the evolving landscape of healthcare and pharmaceutical innovation, the need for robust real-world data (RWD) has never been more critical. This tutorial serves as a comprehensive guide for regulatory, biostatistics, health economics and outcomes research (HEOR), and data standards professionals tasked with selecting the right data partners for high-value RWD collaborations. The focus will be on key criteria for evaluating partnerships with a myriad of real-world data sources, including claims, electronic health records (EHR), patient registries, and digital health data. This is essential not just to meet regulatory expectations but…
Linking claims, EHR and registry data for richer RWE insights
Linking Claims, EHR and Registry Data for Richer RWE Insights In the evolving landscape of healthcare, the utilization of real-world data sources is becoming increasingly crucial for driving evidence-based decision making. Regulatory, biostatistics, health economics and outcomes research (HEOR), and data standards professionals in the pharmaceutical and medtech industries are particularly focused on harnessing the robust insights available from claims data, electronic health records (EHR), patient registries, and digital health data. This article presents a comprehensive step-by-step guide for linking these diverse data sources in compliance with US FDA regulations, as well as comparing practices in the UK and EU…